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Congenital poikiloderma is characterized by a combination of mottled pigmentation, telangiectasia, and epidermal atrophy in the first
few months of life. We have previously described a South African European-descent family affected by a rare autosomal-dominant form
of hereditary fibrosing poikiloderma accompanied by tendon contracture, myopathy, and pulmonary fibrosis. Here, we report the iden-
tification of causative mutations in FAM111B by whole-exome sequencing. In total, three FAM111Bmissense mutations were identified
in five kindreds of different ethnic backgrounds. The mutation segregated with the disease in one large pedigree, and mutations were de
novo in two other pedigrees. All three mutations were absent from public databases and were not observed on Sanger sequencing of 388
ethnically matched control subjects. The three single-nucleotide mutations code for amino acid changes that are clustered within a
putative trypsin-like cysteine/serine peptidase domain of FAM111B. These findings provide evidence of the involvement of FAM111B
in congenital poikiloderma and multisystem fibrosis.Poikiloderma is characterized by mottled pigmentation,
telangiectasia, and epidermal atrophy (Figure 1). The epon-
ymous Weary form of hereditary sclerosing poikiloderma
(MIM 173700), Rothmund-Thomson syndrome (RTS
[MIM 268400]), and Werner syndrome (WRN [MIM
277700]) are well-documented types of inherited poikilo-
derma.1–3 We previously described a distinct autosomal-
dominant form of hereditary fibrosing poikiloderma
(HFP) in a South African family.4 In this two-generation
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gressive pulmonary fibrosis. Clinical manifestations were
poikiloderma from early childhood and telangiectasia
and pigmentary anomalies especially on the face and
sun-exposed areas. Tendon contractures especially
involved the ankles and feet and caused gait disturbance.
Pulmonary involvement was noted during the second
decade of life, and progressive dyspnea and restrictive
impairment of lung function were linked to pulmonary
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This study was approved by the institutional review
boards of the Hospital of Nantes and the University of
Cape Town, and written informed consent was obtained
from each adult participant and the parents of the partici-
pating children. We identified four additional cases that
validated HFP with tendon contracture, myopathy, and
pulmonary fibrosis as a distinct entity. Affected persons
were of French, Algerian, Italian, and Moroccan origins.
The first affected person (individual II2 in family 1 [F1-
II2]), a French boy born to nonconsanguineous parents,
presented with a photodistributed poikiloderma at
1 month of age (Figures 1A and 1B). He also had eczema-
tous lesions of the hands and feet, alopecia (involving
the scalp, eyebrows, and eyelashes), and heat intolerance
causing hypohidrosis (Figures 1C and 1D). Nails, teeth,
and developmental milestones were normal. He developed
lymphoedema of all limbs, complicated by cellulitis at 6
years of age, which was accompanied by rapidly progres-
sive muscle weakness and tendon contractures of both
feet, necessitating Achilles tendon lengthening at 7 years
of age. Blood tests (including full blood count, autoim-
mune screen, and serum creatine kinase) were normal
except for eosinophilia. Electromyography (EMG) showed
a myogenic pattern of the lower limbs, and MRI of skeletal
muscle revealed a diffuse fatty infiltration, especially
affecting the anterior thigh and posterior leg muscles
(Figure 1G). The vastus lateralis muscle biopsy confirmed
an extensive fatty infiltration in which residual muscle tis-
sue was composed of fragmented muscle fascicles with
either normal or dystrophic myocytes (Figure 1I). Neither
neurogenic features nor necrosis was identified by histo-
chemical studies and immunolabeling. N-CAM (CD56)-
positive fibers were, however, observed in most dystrophic
areas. Focal nerve proliferation was seen. Microscopic ex-
amination of skin biopsies revealed epidermal atrophy
and conspicuous alterations of the elastic network in the
superficial and deep dermal layers. Enlarged and frag-
mented elastic fibers and the formation of elastic globules
in the papillary dermis were accompanied by a diffuse
collagen sclerosis (Figure 1L).
The second affected person (individual II-4 in family 2
[F2-II4]) was a 30-year-old man with no family history of
poikiloderma and normal developmental milestones and
was born to consanguineous Algerian parents (Figure 1E).
He had a history of congenital poikiloderma (worse on
the cheeks) and biceps brachii muscle contractures from
early childhood. He developed contractures of the triceps
surae muscles at the age 6 of years, requiring Achilles
tendon lengthening at 11 years of age. By the age of 30
years, he had dysphagia and severe difficulties with
mobility as a result of multiple contractures of the arms
and digits, scoliosis, and impaired lung function. Serum
creatine kinase was slightly increased (460 IU/l). Muscle
MRI showed fat infiltration, but the tibialis anterior and
the posterior compartment of the thigh were spared
(Figure 1H). Muscle biopsy of the left deltoid muscle re-
vealed extensive fatty infiltration with focal lymphocyticThe American Jou(CD3þ) and macrophage (CD68þ) infiltrates without asso-
ciated necrosis or regeneration. Nonspecific myogenic
lesions without any neurogenic features (i.e., normal
ATPase pattern) were found on histochemistry
(Figure 1J). An immunoblot analysis showed a decreased
quantity of calpain.
The third affected person (individual II1 in family 3 [F3-
II1]) was a girl born to nonconsanguineous Italian parents.
At 13 years of age, she was referred with congenital poiki-
loderma and growth retardation. She presented with alope-
cia (involving the scalp, eyebrow, and eyelashes) and nail
dysplasia. She was underweight (body mass index of
14.3 kg/m2) and had short stature (height 145 cm [1.5
SDs]) and delayed puberty, which were attributed to
rickets. She also had contractures of the biceps brachii
and triceps surae muscles, diffuse muscle atrophy and
weakness, and thoracolumbar scoliosis, lower-limb lym-
phoedema, and hepatomegaly. Blood tests revealed chole-
stasis, which was treated with ursodesoxycholic acid.
The fourth affected person (individual II1 in family 4
[F4-II1]) was a 6-year old girl who had no family history
of poikiloderma and was the only daughter of a French
mother and a Moroccan father. She presented with
congenital poikiloderma of the face and extremities,
diffuse alopecia, and anhidrosis (Figure 1F). Frequent falls
and delayed walking were noted by 18 months of age.
She developed progressive muscle weakness, contractures
of the triceps muscles and wrist extensors, and lymphe-
dema of the extremities by 4 years of age and required a
wheelchair at 6 years of age. Cognitive development was
normal. Electroencephalography revealed multifocal
spike-and-wave discharges without clinical seizures. Serum
creatine kinase was slightly increased in infancy (340 IU/l).
EMG showed a myogenic profile at 22 months. On muscle
biopsy, fatty infiltration was associated with heteroge-
neous degeneration of fragmented muscle fascicles. No
necrosis or regeneration was observed, but numerous
N-CAM-positive cells were seen, especially in the most
dystrophic parts (Figure 1K). ATPase patterns and themito-
chondrial network were normal. Focal nerve proliferation
was present. Skin biopsy was in favor of RTS, but this diag-
nosis was ruled out because genetic testing failed to detect
any RECQL4 (MIM 603780) mutation.
A whole-exome sequencing strategy was first applied
to members from two of the families affected by HFP
with tendon contracture, myopathy, and pulmonary
fibrosis: individual F1-II2 and his two unaffected parents
from French family 1 (trio design) and three affected sib-
lings (one deceased) and their unaffected mother from
the South African family (Figure 2 and Figure S1, available
online). Whole-exome sequencing was carried out by
Oxford Gene Technology in the French family and at the
Institute of Genetic Medicine at Newcastle University in
the South African family. In both families, capture was
done with the SureSelect XT Human All Exon V4 kit
(Agilent Technologies) and was followed by Illumina
sequencing. Read files (Fastq) were generated from thernal of Human Genetics 93, 1100–1107, December 5, 2013 1101
Figure 1. Clinical, Imaging, and Pathological Data of Affected Individuals with FAM111B Mutations
(A and B) Facial skin lesions of poikiloderma with hypopigmentation, telangiectasiae, epidermal atrophy, and alopecia of the scalp, eye-
brows, and eyelashes in individual F1-II2 at the age of 12 months (A) and improvement of the lesions at 7 years (B).
(C and D) Eczema-like dermatosis of the hands (C) and the feet (D) in individual F1-II2 were associated with chronic lymphoedema.
(E and F) Facial lesions in individuals F2-II4 (E) and F4-II1 (F).
(G and H)Muscle MRI (T1-weighted sequence) shows a diffuse bright appearance of the anterior compartment of the thighs, particularly
in the vastus lateralis muscles in individual F1-II2 at 7 years (G) and at a more severe stage with a relative sparing of the posterior
compartment in the 30-year-old F2-II4 (H).
(legend continued on next page)
1102 The American Journal of Human Genetics 93, 1100–1107, December 5, 2013
Figure 2. Pedigrees of the Participating HFP-Affected Families
The families are related to the four affected individuals (F1-II2, F2-II4, F3-II1, and F4-II1) described in the present report and to the three
additional affected members (FSA-II3, FSAII-4, and FSA-II5) from the South African family previously reported.4 Affected individuals are
represented by a solid square or circle, depending upon the gender, and index cases are indicated by arrows. Of note, the twins in family 4
have not been born yet. Individuals tested by exome and/or Sanger sequencing are marked by an asterisk, and their genotypes are noted
below in boxes: WT indicates a wild-type genotype, whereas the three different mutations observed in FAM111B (RefSeq NM_198947.3:
c.1861T>G [p.Tyr621Asp], c.1879A>G [p.Arg627Gly], and c.1883G>A [p.Ser628Asn]) are numbered 1–3.sequencing platform with the manufacturer’s proprietary
software. Reads were mapped to their location in build
hg19 (UCSC Genome Browser) of the human reference
genome with the Burrows-Wheeler Aligner package
(v.0.6.1). Local realignment of the mapped reads around
potential indel sites was carried out with the Genome
Analysis Toolkit (GATK; v.1.6).5 Duplicate reads were
marked with Picard and discarded. SNPs and indel variants
were called with the GATK Unified Genotyper for each
sample. SNP novelty was determined against dbSNP re-
leases 132 and 135, 1000 Genomes (releases from 2010
to 2012), and the National Heart, Lung, and Blood Insti-
tute (NHLBI) Exome Sequencing Project Exome Variant
Server (ESP6500). Given the dominant mode of inheri-
tance inferred from the original description,4 we focused
on heterozygous de novo mutations in F1-II2. Candidate
de novo mutations were determined with KGGSeq v.0.36
in the French simplex family, and these were cross-refer-
enced to the list of heterozygous potentially damaging var-
iants that were present in the affected siblings but absent
from their unaffected mother in the South African family.
FAM111B (RefSeq accession number NM_198947.3)
appeared as the only candidate gene in common between
the two families: c.1879A>G (p.Arg627Gly) was the
unique de novo variant found in F1-II2, whereas
c.1861T>G (p.Tyr621Asp) was observed in the affected
South African siblings and absent from their unaffected
mother. DNA from the affected father in the South African
pedigreewas not available for sequencing (Table 1, Figure 2,
and Figure S1). The two rare variants were absent from all
public genetic variant databases tested and they were vali-
dated by Sanger sequencing.
Direct mutation analysis of FAM111B was performed by
Sanger sequencing in the three additional simplex individ-(I–N) Muscle and skin microscopy. (I) Fatty tissue and fragmented mu
Hematoxylin and eosin staining [H&E]; 320 magnification). (J) No
nuclei, and splitting (individual F2-II4; Gomori trichrome; 3150
3150 magnification). (L) N-CAM-positive myocytes in dystrophic
(Dako); 3100 magnification). (M) Elastic dystrophy (arrowheads) wit
ual F1-II2; Weigert staining; 3150 magnification). (N) Age-matched
The American Jouuals (F2-II4, F3-II1, and F4-II1 in Figure 2). Although they
were unrelated and of different ancestries, individuals F2-
II4 and F3-II1 had the same FAM111B variant as individual
F1-II2; the de novo occurrence of the mutation was
confirmed in individual F2-II4, but this could not be tested
in individual F3-II1 because no parental samples were
available. Individual F4-II1 was found to have the variant
c.1883G>A (p.Ser628Asn), located one codon downstream
of the de novomutation (Figure S1) and absent from public
genetic variant databases; only the mother of individual
F4-II1 could be tested, and she did not have the mutation.
All three putative causative variants were absent on Sanger
sequencing of 388 healthy controls, including 96 Algerian,
127 Moroccan (half Berber and half Arab), and 165 South
African (93 of white European origin and 72 of mixed
ancestry) individuals. All three variants were predicted to
be deleterious by bioinformatic programs PolyPhen-2 and
SIFT and affect amino acids conserved across mammalian
species or primates (Figure S1 and Table S1).
Together, the identification of (1) three rare heterozy-
gous mutations in affected members of five unrelated
families with differing ethnic backgrounds and a concor-
dant phenotype and (2) a de novo occurrence in two fam-
ilies provide compelling genetic evidence that mutations
in FAM111B cause HFP with tendon contracture, myop-
athy, and pulmonary fibrosis. Given that several putative
loss-of-function variants (stop-gain and frameshift) are
present in the NHLBI Exome Variant Server, i.e., in individ-
uals very unlikely to be affected by HFP, we hypothesize
that the FAM111B mutations are either gain-of-function
or dominant-negative variants.
Very little is known about FAM111B, which is the second
and last member of the ‘‘family with sequence similarity
111’’ gene family (Figure S2). It encodes a protein predictedscle fascicles; heterogeneous dystrophic pattern (individual F1-II2;
nspecific myopathic changes with variation in fiber size, internal
magnification). (K) Age-matched normal muscle fascicles (H&E;
fascicles (individual F4-II1; immunolabeling with a DAB system
h conspicuous superficial dermal changes on skin biopsy (individ-
normal skin biopsy (Weigert staining; 3150 magnification).
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Table 1. Clinical Characteristics of the Index Cases
Characteristics
Individual
F1-II2
Individual
F2-II4
Individual
F3-II1
Individual
F4-II1 South African Family4
Sex male male female female female (proband) male (father) male (brother) male (brother)
Age at last
examination
7 years 30 years 14 years 6 years 26 years (death at
56 years)
(death at
30 years)
31 years
General
Growth retardation  þ þ     
Delayed puberty ND þ þ ND ND ND ND ND
Skin
Congenital
poikiloderma
þ þ þ þ þ þ þ þ
Face þ þ þ þ þ þ þ þ
Exposed area þ þ þ þ þ þ þ þ
Upper and/or
lower limbs
þ þ þ þ þ þ þ þ
Eczematiform þ þ ND þ    
Psoriasiform   ND þ    
Erysipelas þ  þ     
Lymphoedema
of extremities
þ  þ þ    
Sclerosis of
the digits
 þ   þ ND ND þ
Hypohidrosis
and/or heat
intolerance
þ þ ND þ þ þ þ þ
Hair
Hypotrichosis
and/or alopecia
þ þ þ þ þ ND ND þ
Scalp hair þ þ þ þ þ þ þ þ
Eyebrows þ þ þ þ þ þ þ þ
Eyelashes þ þ þ þ    
Follicular dystrophy  ND ND ND ND ND ND ND
Nails
Dysplasia   þ     
Muscle
Muscle weakness
(age of onset)
þ (7 years) þ (11 years) þ (4 years) þ (14
months)
þ (9 years) ND ND ND
Proximal
lower limbs
þ þ þ þ ND ND ND ND
Distal lower
limbs
þ þ þ ND ND ND ND ND
Proximal
upper limbs
þ þ þ ND ND ND ND ND
Distal upper
limbs
þ þ þ þ ND ND ND ND
Neck extensors  þ ND ND ND ND ND ND
Amyotrophy þ þ þ þ ND ND ND ND
Abolition of
lower-limb
tendon reflexes
ND þ þ þ ND ND ND ND
(Continued on next page)
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Table 1. Continued
Characteristics
Individual
F1-II2
Individual
F2-II4
Individual
F3-II1
Individual
F4-II1 South African Family4
Tendon
lengthening
(age of onset)
þ (7 years) þ (11 years) þ (13 years)  (ND) þ (14 years)  (ND) þ (5 years)  (ND)
Joints
Distal lower-limb
contractures
and/or pes varus
(age of onset)
þ (6 years) þ (2–3 years) þ þ (2 years) þ ND ND 
Upper-limb
contractures
 þ þ þ  ND ND 
Spine
Scoliosis  þ þ     
Lungs
Restrictive syndrome þ þ ND ND þ þ þ ND
Liver
Hepatomegaly  ND þ     
Eyes
Cataract   þ     
Blood Test
Serum creatine
kinase (IU/l)
N 460 500 340 ND ND ND ND
Muscle Exploration
EMG: myogenic
profile
þ ND þ þ ND ND ND ND
MRI adiposis adiposis ND ND ND ND ND ND
Pathology
Peripheral
skeletal muscle
adiposis dystrophy,
fibrosis,
adiposis
dystrophy,
fibrosis,
adiposis
fibrosis,
atrophy
ND ND fatty
infiltration
ND
Skin sclerodermiform
aspect, fibrosis,
elastic tissue
degeneration
ND ND RTS-like ND ND sclerodermiform
aspect, fibrosis,
elastic tissue
degeneration
ND
Visceral organs ND ND ND ND ND pulmonary
fibrosis
pulmonary,
esophageal,
and mediastinal
lymph node
fibrosis; pancreas
fatty infiltration
ND
Vasculature ND ND ND ND ND ND elastic
degeneration,
medial
calcification
ND
Mutational Analysis
RECQL4     ND   ND
Other candidate
genes
 CAPN3,
LMNA, CAV3
(no mutation)
 SMN1
(no
mutation)
   
FAM111B c.1879A>G
(p.Arg627Gly)
c.1879A>G
(p.Arg627Gly)
c.1879A>G
(p.Arg627Gly)
c.1883G>A
(p.Ser628Asn)
c.1861T>G
(p.Tyr621Asp)
ND c.1861T>G
(p.Tyr621Asp)
c.1861T>G
(p.Tyr621Asp)
The following abbreviations are used: EMG, electromyography; N, normal; ND, not documented; and RTS, Rothmund-Thomson syndrome.
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to contain a trypsin-like cysteine/serine peptidase domain
split into two parts by a loop that harbors the three alter-
ations identified in the affected individuals in the present
study (Figure S3). The cluster of alterations in this small
region suggests that it has an important role in the func-
tional activity of FAM111B. This domain is 45% homolo-
gous to the one predicted in FAM111A (Figure S4), which
contains causative mutations for Kenny-Caffey syndrome
(KCS [MIM 127000]) and osteocraniostenosis (OCS [MIM
602361]), two clinical entities that are very different from
HFP.7 Predictions of the two- and three-dimensional pro-
tein structures of FAM111B suggest that the amino acid
residue 621 (p.Tyr621Asp) is located in a b sheet, whereas
residues 627 (p.Arg627Gly) and 628 (p.Ser628Asn) lie
either in a b sheet or in a random coil (Figures S5–S7).
Physical interactions between FAM111B and polyubiqui-
tin-C (UBC)8,9 and ATP13A210 have been detected
experimentally. FAM111B was detected in skeletal
striated muscle, but not in fibroblasts, by immunoblot
analysis of tissue samples from individual F1-II2
(Figure S8). FAM111BmRNA expression has been detected
in many tissues, including skin, skeletal muscle, and
trachea. (Figures S9 and S10). We found that in normal
fibroblasts, protein levels were undetectable and mRNA
expression was low.
The phenotype of our cases differs from other types of
hereditary poikiloderma, such as RTS, WRN, and Kindler
syndrome (MIM 173650).1,2,11,12 Of note, skin lesions
improved with time (Figure 1), whereas extracutaneous
symptoms became more prominent. Furthermore, tendon
contracture, progressive muscle weakness, and pulmonary
fibrosis have not been described in other types of heredi-
tary poikiloderma. Nevertheless, Meier has reported an
adult with putative RTS associated with progressive muscle
atrophy, multiple organ fibrosis, and pulmonary
cachexia.13 We postulate that simplex cases of congenital
poikiloderma with muscular atrophy, organ fibrosis, or
pulmonary involvement and no RECQL4mutations might
represent HFP related to FAM111B. The phenotype
described here also differs from Clericuzio-type poikilo-
derma with neutropenia (MIM 604173), due to mutations
in C16orf57 (MIM 61327), which encodes the highly
conserved USB1, given that there was no associated
neutropenia.6,14,15 The Weary form of hereditary poikilo-
derma is characterized by cutaneous fibrous bands, subcu-
taneous calcification, and/or valvular heart disease, which
were not observed in our series.3,16
Histological examination of skeletal muscle in our cases
revealed a partial loss of muscle tissue associated with
extensive fibrofatty tissue infiltration regardless of age.
There was no indication of denervation, necrosis, or
inflammation (except for one isolated focus of inflamma-
tory cells in individual F2-II4). No noticeable labeling
was observed with many different antibodies, except for
N-CAM, which was present in individuals F1-II2 and F4-
II1. The fatty tissue might be considered either as a passive
phenomenon due to muscle degeneration or as an active1106 The American Journal of Human Genetics 93, 1100–1107, Deceprocess invading normalmuscle tissue and leading to a sec-
ondary myopathic destruction. The skin pathology is
remarkable for collagen sclerosis, elastic degeneration,
and the absence of fatty infiltration, in contrast to the
observation made in muscle tissue.
Our results led us to suspect that HFP involves genotype-
phenotype correlations similar to those seen in OCS and
KCS, due to FAM111A (MIM 615292) mutations.7 Muta-
tions in FAM111B codons 627 and 628 indeed appear to
be associated with early disease onset (in affected members
from families 1–4); however, the symptoms caused by
the mutation in codon 621 occurred later in the South
African family, which enabled the familial transmission
of the anomaly. We postulate that mutations in other
regions of FAM111B might lead to phenotypes different
from HFP, as observed, for instance, for Hajdu-Cheney
(MIM 102500) and Alagille (MIM 610205) syndromes,
which are caused by mutations located in different coding
regions of the same gene, NOTCH2 (MIM 600275).17,18 As
a matter of fact, in the South African family, the postmor-
tem study of one affected member revealed a diffuse fatty
infiltration and fibrosis of organs such as the lungs, esoph-
agus, and pancreas. The lung-function impairment in
individuals F1-II2 and F2-II4 and the presence of hepato-
megaly in individual F3-II1 probably have the same
origin, supporting that FAM111B has a multisystemic
involvement that could lead to other phenotypes not yet
related to this gene. Nevertheless, these tentative observa-
tions remain to be confirmed in a larger series of affected
people.
In conclusion, we have demonstrated that mutations in
FAM111B cause HFP with tendon contracture, myopathy,
and pulmonary fibrosis. Our findings identify FAM111B
as a critical gene in the development of fibrosis, which is
a key pathological process in many human diseases.Supplemental Data
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